Neurocrine Bio. (NBIX) PT Raised to $180 at Jefferies
Tweet
Share
E-mailGet Alerts NBIX Hot Sheet
Price: $152.72 +1.26%
Rating Summary:
30 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 6 | Down: 4 | New: 7
Rating Summary:
30 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 6 | Down: 4 | New: 7
Join SI Premium – FREE
Jefferies analyst Akash Tewari raised the price target on Neurocrine Bio. (NASDAQ: NBIX) to $180.00 (from $161.00) while maintaining a Buy rating.
You May Also Be Interested In
- Berenberg Upgrades Accelleron Industries AG (ACLN:SW) to Buy
- TUI AG (TUI1:GR) (TUIFY) PT Lowered to EUR7.20 at Citi
- JPMorgan Upgrades Resona Holdings, Inc (8308:JP) (RSNHF) to Overweight
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
